Optimal Adjuvant Endocrine Treatment of ER+/HER2+ Breast Cancer Patients by Age at Diagnosis: A Population-Based Cohort Study

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2017.11.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study

PLoS ONE
Multidisciplinary
2015English

Optimal Treatment of Early Stage HER2-positive Breast Cancer

Cancer
Cancer ResearchOncology
2018English

Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?

Oncology in Clinical Practice
Oncology
2019English

A miRNA-based Signature Predicts Development of Disease Recurrence in HER2 Positive Breast Cancer After Adjuvant Trastuzumab-Based Treatment

Scientific Reports
Multidisciplinary
2016English

Breast Cancer Subtypes Among Iraqi Patients: Identified by Their ER, PR and HER2 Status

Journal of the faculty of medicine baghdad
2017English

Risk and Predictors of Psoriasis in Patients With Breast Cancer: A Swedish Population-Based Cohort Study

BMC Medicine
Medicine
2017English

Population Based Utilization of Radiation Therapy by a Canadian Breast Cancer Cohort

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pregnancy at Very Advanced Maternal Age: A UK Population-Based Cohort Study

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2016English

Impacts of Smoking on Endocrine Treatment Response in a Prospective Breast Cancer Cohort

British Journal of Cancer
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy